Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc.

The latest announcement is out from Balco Group AB ( ($SE:BALCO) ). Balco Group AB will publish its interim report for the first quarter of 2026 at...

Balco Group Sets Webcast for First-Quarter 2026 Results

Alchemy Investments Acquisition Corp 1 Class A ( ($ALCY) ) has shared an update. On April 7, 2026, Alchemy Investments Acquisition Corp 1 and Carti...

Alchemy Investments Announces Investor Presentation on Cartiga Merger

Geopolitical tensions in the Middle East and elevated oil prices continue to rattle investors. Given an uncertain backdrop, investors looking for l...

Best ETFs to Invest In, According to AI Analyst

Alcon ( ($CH:ALC) ) has issued an announcement. On April 2, 2026, Alcon published the agenda for its Annual General Meeting, to be held in person o...

Alcon Sets April 30, 2026 AGM, Proposes New Director and CHF 0.28 Dividend

The latest announcement is out from Alternus Clean Energy ( ($ALCE) ). On March 27, 2026, Alternus Clean Energy, Inc. raised $1 million in gross pr...

Alternus Clean Energy Converts Debt via Preferred Equity Issuance

Balco Group AB ( ($SE:BALCO) ) has provided an announcement. Balco Group AB has called its Annual General Meeting for 5 May 2026 in Växjö, offering...

Balco Group Sets May Date and Voting Rules for 2026 AGM

Kepler Capital analyst Hugo Paternoster maintained a Hold rating on Cegedim on March 27 and set a price target of €14.00. The company’s shares clos...

Kepler Capital  Reaffirms Their Hold Rating on Cegedim (0DYQ)

Kepler Capital analyst Thomas Renaud maintained a Buy rating on Claranova SA on March 26 and set a price target of €2.60. The company’s shares clos...

Kepler Capital  Sticks to Its Buy Rating for Claranova SA (0N6K)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Rubicon Organics (ROMJF), Alcon (ALC) and Milestone ...

Analysts Offer Insights on Healthcare Companies: Rubicon Organics (OtherROMJF), Alcon (ALC) and Milestone Pharmaceuticals (MIST)

An announcement from Alchemy Investments Acquisition Corp 1 Class A ( ($ALCY) ) is now available. On March 24, 2026, Alchemy Investments Acquisitio...

Alchemy, Cartiga Explore PIPE Financing for Proposed Merger

Alico ( ($ALCO) ) just unveiled an update. On March 24, 2026, Alico, Inc. announced that its Board of Directors had declared a second-quarter fisca...

Alico Declares Modest Second-Quarter 2026 Cash Dividend

Balco Group AB ( ($SE:BALCO) ) has shared an announcement. Balco Group AB’s Nomination Committee has proposed a new six-member Board of Directors, ...

Balco Group Proposes New Chairman and Board Line-Up

Clear Street analyst William Maughan maintained a Buy rating on Cellectis SA today and set a price target of $9.00. Maughan covers the Healthcare s...

Clear Street Reaffirms Their Buy Rating on Cellectis SA (CLLS)

MA Financial Group analyst Sinclair Currie maintained a Buy rating on Alcidion Group Limited today and set a price target of A$0.15. According to T...

MA Financial Group Keeps Their Buy Rating on Alcidion Group Limited (ALC)

In a report released today, Graham Doyle from UBS maintained a Buy rating on Alcon, with a price target of CHF95.00. According to TipRanks, Doyle i...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALC	$77.29	+3.51%	1.32M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALC	$77.29	+3.5%	1.32M
3
4
5
6

ALC

ALC

Get Alcon Inc. Data in Excel

Get Alcon Inc. Data in Excel